ApoA1

References

• Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 2008; 118:1347 - 1357; PMID: 18809807
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601 - 2610; PMID: 8647954; http://dx.doi.org/10.1172/JCI118709.
   PubMed Web of Science ®Google Scholar
• Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complications 2007; 21:149 - 157; PMID: 17493547; http://dx.doi.org/10.1016/j.jdiacomp.2005.12.003
   PubMed Web of Science ®Google Scholar
• Hall JE. The kidney, hypertension and obesity. Hypertension 2003; 41:625 - 633; PMID: 12623970; http://dx.doi.org/10.1161/01.HYP.0000052314.95497.78
   PubMed Web of Science ®Google Scholar
• Sodhi K, Inoue K, Gotlinger KH, Canestraro M, Vanella L, Kim DH, et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 2009; 331:906 - 916; PMID: 19717790; http://dx.doi.org/10.1124/jpet.109.157545
   PubMed Web of Science ®Google Scholar
• Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK and pAKT in obese mice. J Lipid Res 2009; 50:1293 - 1304; PMID: 19224872; http://dx.doi.org/10.1194/jlr.M800610-JLR200
   PubMed Web of Science ®Google Scholar
• Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S, et al. L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice. J Lipid Res 2008; 49:1658 - 1669; PMID: 18426778; http://dx.doi.org/10.1194/jlr.M800046-JLR200
   PubMed Web of Science ®Google Scholar
• Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008; 57:1526 - 1535; PMID: 18375438; http://dx.doi.org/10.2337/db07-1764
   PubMed Web of Science ®Google Scholar
• Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 1976; 5:299 - 311; PMID: 1085232; http://dx.doi.org/10.1016/S0300-595X(76)80023-0
   PubMedGoogle Scholar
• Roncari DA, Lau DC, Kindler S. Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism 1981; 30:425 - 427; PMID: 7231183; http://dx.doi.org/10.1016/0026-0495(81)90174-8
   PubMed Web of Science ®Google Scholar
• Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab 2009; 20:107 - 114; PMID: 19269847; http://dx.doi.org/10.1016/j.tem.2008.11.005
   PubMed Web of Science ®Google Scholar
• Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007; 131:242 - 256; PMID: 17956727; http://dx.doi.org/10.1016/j.cell.2007.10.004
   PubMed Web of Science ®Google Scholar
• Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272:263 - 267; PMID: 8602510; http://dx.doi.org/10.1126/science.272.5259.263
   PubMed Web of Science ®Google Scholar
• Lecka-Czernik B, Rosen CJ, Kawai M. Skeletal aging and the adipocyte program: New insights from an “old” molecule. Cell Cycle 2010; 9:3648 - 3654; PMID: 20890120; http://dx.doi.org/10.4161/cc.9.18.13046
   PubMed Web of Science ®Google Scholar
• Zafren K, Feldman J, Becker RJ, Williams SR, Weiss EA, Deloughery T. D-dimer is not elevated in asymptomatic high altitude climbers after descent to 5,340?m: the Mount Everest Deep Venous Thrombosis Study (Ev-DVT). High Alt Med Biol 2011; 12:223 - 227; PMID: 21962065; http://dx.doi.org/10.1089/ham.2010.1101
   PubMed Web of Science ®Google Scholar
• Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006; 47:1108 - 1116; PMID: 16651465; http://dx.doi.org/10.1161/01.HYP.0000222368.43759.a1
   PubMed Web of Science ®Google Scholar
• Wang ZV, Scherer PE. Adiponectin, cardiovascular function and hypertension. Hypertension 2008; 51:8 - 14; PMID: 17998473; http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.099424
   PubMed Web of Science ®Google Scholar
• Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002; 51:2325 - 2328; PMID: 12086969; http://dx.doi.org/10.2337/diabetes.51.7.2325
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) 2003; 228:1111 - 1117; PMID: 14610248
   PubMed Web of Science ®Google Scholar
• Kotani K, Sakane N, Saiga K, Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 2005; 48:2684 - 2686; PMID: 16261311; http://dx.doi.org/10.1007/s00125-005-0015-4
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752 - 1761; PMID: 15599400
   PubMed Web of Science ®Google Scholar
• Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006; 49:784 - 791; PMID: 16501941; http://dx.doi.org/10.1007/s00125-006-0170-2
   PubMed Web of Science ®Google Scholar
• Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Falck JR, et al. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat 2011; 96:54 - 62; PMID: 21821145; http://dx.doi.org/10.1016/j.prostaglandins.2011.07.005
   PubMed Web of Science ®Google Scholar
• Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006; 13:419 - 425; PMID: 17053453; http://dx.doi.org/10.1097/01.moh.0000245697.54887.6f
   PubMed Web of Science ®Google Scholar
• Vanella L, Kim DH, Asprinio D, Peterson SJ, Barbagallo I, Vanella A, et al. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 2010; 46:236 - 243; PMID: 19853072; http://dx.doi.org/10.1016/j.bone.2009.10.012
   PubMed Web of Science ®Google Scholar
• Yu F, Takahashi T, Moriya J, Kawaura K, Yamakawa J, Kusaka K, et al. Angiotensin-II receptor antagonist alleviates non-alcoholic fatty liver in KKAy obese mice with type 2 diabetes. J Int Med Res 2006; 34:297 - 302; PMID: 16866024
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mangalat D, Korbut R. Adipocytokines—novel link between inflammation and vascular function?. J Physiol Pharmacol 2006; 57:505 - 528; PMID: 17229978
   PubMed Web of Science ®Google Scholar
• Chevillotte E, Giralt M, Miroux B, Ricquier D, Villarroya F. Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 2007; 56:1042 - 1050; PMID: 17395745; http://dx.doi.org/10.2337/db06-1300
   PubMed Web of Science ®Google Scholar
• Christodoulides C, Laudes M, Cawthorn WP, Schinner S, Soos M, O'Rahilly S, et al. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci 2006; 119:2613 - 2620; PMID: 16763196; http://dx.doi.org/10.1242/jcs.02975
   PubMed Web of Science ®Google Scholar
• Kawai M, Mushiake S, Bessho K, Murakami M, Namba N, Kokubu C, et al. Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem Biophys Res Commun 2007; 363:276 - 282; PMID: 17888405; http://dx.doi.org/10.1016/j.bbrc.2007.08.088
   PubMed Web of Science ®Google Scholar
• Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002; 277:30998 - 31004; PMID: 12055200; http://dx.doi.org/10.1074/jbc.M204527200
   PubMed Web of Science ®Google Scholar
• Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289:950 - 953; PMID: 10937998; http://dx.doi.org/10.1126/science.289.5481.950
   PubMed Web of Science ®Google Scholar
• Okamura M, Kudo H, Wakabayashi K, Tanaka T, Nonaka A, Uchida A, et al. COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis. Proc Natl Acad Sci USA 2009; 106:5819 - 5824; PMID: 19307559; http://dx.doi.org/10.1073/pnas.0901676106
   PubMed Web of Science ®Google Scholar
• Ahn J, Lee H, Kim S, Ha T. Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am J Physiol Cell Physiol 2010; 298:1510 - 1516; PMID: 20357182; http://dx.doi.org/10.1152/ajpcell.00369.2009
   PubMed Web of Science ®Google Scholar
• Kamei Y, Suganami T, Kohda T, Ishino F, Yasuda K, Miura S, et al. Peg1/Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner. FEBS Lett 2007; 581:91 - 96; PMID: 17182038; http://dx.doi.org/10.1016/j.febslet.2006.12.002
   PubMed Web of Science ®Google Scholar
• Takahashi M, Kamei Y, Ezaki O. Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab 2005; 288:117 - 124; PMID: 15353408; http://dx.doi.org/10.1152/ajpendo.00244.2004
   PubMed Web of Science ®Google Scholar
• Li M, Peterson S, Husney D, Inaba M, Guo K, Kappas A, et al. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 2007; 6:567 - 571; PMID: 17299269; http://dx.doi.org/10.4161/cc.6.5.3917
   PubMed Web of Science ®Google Scholar
• Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60:79 - 127; PMID: 18323402; http://dx.doi.org/10.1124/pr.107.07104
   PubMed Web of Science ®Google Scholar
• Cao J, Inoue K, Sodhi K, Puri N, Peterson SJ, Rezzani R, et al. High-Fat Diet Exacerbates Renal Dysfunction in SHR: Reversal by Induction of HO-1-Adiponectin Axis. Obesity (Silver Spring) 2011; In press PMID: 22193921; http://dx.doi.org/10.1038/oby.2011.365
   PubMed Web of Science ®Google Scholar
• Sodhi K, Puri N, Inoue K, Falck JR, Schwartzman ML, Abraham NG. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat 2011; In press PMID: 22209722; http://dx.doi.org/10.1016/j.prostaglandins.2011.12.004
   PubMed Web of Science ®Google Scholar
• Hiwasa T, Fujiki H, Sugimura T, Sakiyama S. Increase in the synthesis of a Mr. 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates. Cancer Res 1983; 43:5951 - 5955; PMID: 6416671
   PubMed Web of Science ®Google Scholar
• Kim DH, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA, et al. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J Pharmacol Exp Ther 2008; 325:833 - 840; PMID: 18334666; http://dx.doi.org/10.1124/jpet.107.135285
   PubMed Web of Science ®Google Scholar
• Kappas A, Drummond GS, Munson DP, Marshall JR. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics 2001; 108:1374 - 1377; PMID: 11731664; http://dx.doi.org/10.1542/peds.108.6.1374
   PubMed Web of Science ®Google Scholar
• Miller M, Cho JY, Pham A, Ramsdell J, Broide DH. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009; 182:684 - 691; PMID: 19109202
   PubMed Web of Science ®Google Scholar
• Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, et al. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 2003; 93:507 - 514; PMID: 12933701; http://dx.doi.org/10.1161/01.RES.0000091828.36599.34
   PubMed Web of Science ®Google Scholar
• Chang SH, Barbosa-Tessmann I, Chen C, Kilberg MS, Agarwal A. Glucose deprivation induces heme oxygenase-1 gene expression by a pathway independent of the unfolded protein response. J Biol Chem 2002; 277:1933 - 1940; PMID: 11707454; http://dx.doi.org/10.1074/jbc.M108921200
   PubMed Web of Science ®Google Scholar
• Chang SH, Garcia J, Melendez JA, Kilberg MS, Agarwal A. Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain. Biochem J 2003; 371:877 - 885; PMID: 12585963; http://dx.doi.org/10.1042/BJ20021731
   PubMed Web of Science ®Google Scholar
• Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, et al. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 2005; 111:3126 - 3134; PMID: 15939814; http://dx.doi.org/10.1161/CIRCULATIONAHA.104.517102
   PubMed Web of Science ®Google Scholar
• Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, et al. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 2004; 315:509 - 516; PMID: 14766238; http://dx.doi.org/10.1016/j.bbrc.2004.01.086
   PubMed Web of Science ®Google Scholar
• Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li Volti G, et al. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 2004; 287:2468 - 2477; PMID: 15284058; http://dx.doi.org/10.1152/ajpheart.01187.2003
   PubMed Web of Science ®Google Scholar
• Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, et al. Upregulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 2006; 319:1144 - 1152; PMID: 16959961; http://dx.doi.org/10.1124/jpet.106.107482
   PubMed Web of Science ®Google Scholar
• Sambuceti G, Morbelli S, Vanella L, Kusmic C, Marini C, Massollo M, et al. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1 and adiponectin. Stem Cells 2009; 27:399 - 407; PMID: 19038792; http://dx.doi.org/10.1634/stemcells.2008-0800
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001; 507:142 - 146; PMID: 11684087; http://dx.doi.org/10.1016/S0014-5793(01)02960-X
   PubMed Web of Science ®Google Scholar
• Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103:129 - 135; PMID: 9884342; http://dx.doi.org/10.1172/JCI4165
   PubMed Web of Science ®Google Scholar
• Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 2002; 33:125 - 130; PMID: 11823983; http://dx.doi.org/10.1053/hupa.2002.30217
   PubMed Web of Science ®Google Scholar
• Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94:10925 - 10930; PMID: 9380736; http://dx.doi.org/10.1073/pnas.94.20.10925
   PubMed Web of Science ®Google Scholar
• Di Noia MA, Van Driesche S, Palmieri F, Yang LM, Quan S, Goodman AI, et al. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem 2006; 281:15687 - 15693; PMID: 16595661; http://dx.doi.org/10.1074/jbc.M510595200
   PubMed Web of Science ®Google Scholar
• Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 2005; 289:701 - 707; PMID: 15821039; http://dx.doi.org/10.1152/ajpheart.00024.2005
   PubMed Web of Science ®Google Scholar
• Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117:2621 - 2637; PMID: 17717599; http://dx.doi.org/10.1172/JCI31021
   PubMed Web of Science ®Google Scholar
• Sardana MK, Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci USA 1987; 84:2464 - 2468; PMID: 3470805; http://dx.doi.org/10.1073/pnas.84.8.2464
   PubMed Web of Science ®Google Scholar
• Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C, et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2006; 2:81; PMID: 16733553; http://dx.doi.org/10.1371/journal.pgen.0020081
   PubMed Web of Science ®Google Scholar
• Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7:885 - 896; PMID: 17139329; http://dx.doi.org/10.1038/nrm2066
   PubMed Web of Science ®Google Scholar